| 注册
首页|期刊导航|中国药房|布拉氏酵母菌对比双歧杆菌三联活菌治疗儿童腹泻有效性和安全性的Meta分析

布拉氏酵母菌对比双歧杆菌三联活菌治疗儿童腹泻有效性和安全性的Meta分析

张潇丹 王瑞芹 刘璐 任美娟 闫美兴

中国药房2024,Vol.35Issue(2):226-230,5.
中国药房2024,Vol.35Issue(2):226-230,5.DOI:10.6039/j.issn.1001-0408.2024.02.18

布拉氏酵母菌对比双歧杆菌三联活菌治疗儿童腹泻有效性和安全性的Meta分析

Meta-analysis of the efficacy and safety of Saccharomyces boulardii versus Bifidobacterium triple live bacteria in the treatment of pediatric diarrhea

张潇丹 1王瑞芹 2刘璐 2任美娟 1闫美兴2

作者信息

  • 1. 中国海洋大学医药学院,山东 青岛 266003
  • 2. 青岛妇女儿童医院药学部,山东 青岛 266034
  • 折叠

摘要

Abstract

OBJECTIVE To compare the efficacy and safety of Saccharomyces boulardii and Bifidobacterium triple live bacteria in the treatment of pediatric diarrhea.METHODS Retrieved from PubMed,Embase,the Cochrane Library,CBM,Wanfang data,CNKI and VIP,randomized controlled trials(RCTs)about S.boulardii(S.boulardii group)versus Bifidobacterium triple liver bacteria(Bifidobacterium group)were collected.After screening the literature,extracting data and evaluating the quality,meta-analysis was performed by using RevMan 5.3 software.RESULTS A total of 9 RCTs were included,involving 898 patients.Results of meta-analysis showed there was no statistical significance in total response rate[OR=1.69,95%CI(0.93,3.09),P=0.09],duration of diarrhea[MD=-1.39,95%CI(-3.35,0.57),P=0.16],the time of abdominal pain disappearance[MD=0.09,95%CI(-0.87,1.05),P=0.86]or the incidence of adverse reactions[OR=0.65,95%CI(0.05,8.03),P=0.74].The number of stools in S.boulardii group was significantly less than Bifidobacterium group[MD=-0.91,95%CI(-1.80,-0.02),P=0.04].The results of subgroup analysis showed that the duration of diarrhea in children with antibiotic-associated diarrhea in S.boulardii group was significantly shorter than Bifidobacterium group(P<0.05).CONCLUSIONS The efficacy and safety of S.boulardii are similar to those of Bifidobacterium in the treatment of diarrhea,but S.boulardii is better than Bifidobacterium in terms of stool number,the duration of diarrhea in children with antibiotic-associated diarrhea.

关键词

布拉氏酵母菌/双歧杆菌三联活菌/儿童腹泻/疗效/安全性/Meta分析

Key words

Saccharomyces boulardii/Bifidobacterium triple live bacteria/pediatric diarrhea/efficacy/safety/meta-analysis

分类

医药卫生

引用本文复制引用

张潇丹,王瑞芹,刘璐,任美娟,闫美兴..布拉氏酵母菌对比双歧杆菌三联活菌治疗儿童腹泻有效性和安全性的Meta分析[J].中国药房,2024,35(2):226-230,5.

基金项目

山东省药学会科研项目(No.SDSYXH-KY-202208) (No.SDSYXH-KY-202208)

中国药房

OA北大核心CSTPCD

1001-0408

访问量12
|
下载量0
段落导航相关论文